Skip to main content

DBZEA

ADVERTISEMENT
Identification
Molecular formula
C22H27N3
CAS number
21462-39-5
IUPAC name
2-(2-benzylbenzimidazol-1-yl)-N,N-diethyl-ethanamine
State
State

As a solid, DBZEA exists at room temperature in a crystalline form.

Melting point (Celsius)
232.00
Melting point (Kelvin)
505.15
Boiling point (Celsius)
454.80
Boiling point (Kelvin)
727.95
General information
Molecular weight
337.45g/mol
Molar mass
337.4510g/mol
Density
1.1200g/cm3
Appearence

DBZEA is typically a white to off-white crystalline powder.

Comment on solubility

Solubility Characteristics of 2-(2-benzylbenzimidazol-1-yl)-N,N-diethyl-ethanamine

The solubility of 2-(2-benzylbenzimidazol-1-yl)-N,N-diethyl-ethanamine can be quite intriguing due to its molecular structure. This compound, which features both aromatic and aliphatic groups, exhibits varying solubility in different solvents. Here are some key points regarding its solubility:

  • Solvent Polarity: The solubility is influenced by the polarity of the solvent. Non-polar solvents may dissolve the compound better due to its hydrophobic elements.
  • Temperature Effects: Generally, increasing temperature can enhance solubility, allowing more of the compound to dissolve.
  • Salt Formation: In polar solvents, the presence of ionic groups may promote solubility through salt formation, facilitating better interaction with the solvent.
  • Hydrogen Bonding: The ability to form hydrogen bonds with solvents can also affect the solubility, as this can stabilize the compound in solution.

Many of the benzimidazole derivatives display limited water solubility but are often soluble in organic solvents such as ethanol and dimethyl sulfoxide (DMSO). This characteristic is important for its application in pharmacology and material science. In conclusion, a good understanding of the solubility characteristics of 2-(2-benzylbenzimidazol-1-yl)-N,N-diethyl-ethanamine can help guide its effective use in various chemical applications.

Interesting facts

Interesting Facts about 2-(2-benzylbenzimidazol-1-yl)-N,N-diethyl-ethanamine

This compound, a derivative of benzimidazole, is fascinating not only due to its complex structure but also because of its potential applications in various fields. Here are some noteworthy aspects:

  • Pharmacological Potential: Compounds featuring the benzimidazole moiety have been widely recognized for their biological activities, including anti-inflammatory, anticancer, and antimicrobial properties. Researchers are investigating this compound’s potential as a therapeutic agent, enhancing its significance in medicinal chemistry.
  • Structural Complexity: The presence of both an amine and a benzimidazole group gives this compound unique steric and electronic properties, which can influence its reactivity and interaction with biological targets.
  • Synthesis: The synthesis of this compound may involve multi-step chemical reactions, which can illustrate principles such as nucleophilic substitution and ring formation. Understanding its synthetic pathway can enhance students' grasp of organic synthesis techniques.
  • Research Interest: Current research often focuses on compounds like this to explore their roles in drug development. The ongoing studies can lead to notable discoveries that can impact medical and pharmaceutical sciences.
  • Versatility: The implementation of a diethyl group alongside the aromatic systems allows for diverse interactions in biochemical applications, making it a prime candidate for further investigation in drug design and development.

Overall, 2-(2-benzylbenzimidazol-1-yl)-N,N-diethyl-ethanamine represents an exciting intersection of organic chemistry and pharmacology. As we explore its properties and application potential, the journey can lead to innovations in therapeutic interventions and materials science.

Synonyms
RL4C6UA9R2
UNII-RL4C6UA9R2
(2-(2-Benzyl-benzoimidazol-1-yl)-ethyl)-diethyl-amine
1-Diethylaminoethyl-2-benzyl-benzimidazole
17817-67-3
2-Benzyl-1-(2-(diethylamino)ethyl)benzimidazole
Benzimidazole, 2-benzyl-1-(2-(diethylamino)ethyl)-
N,N-Diethyl-2-(phenylmethyl)-1H-benzimidazole-1-ethanamine
1H-Benzimidazole-1-ethanamine, N,N-diethyl-2-(phenylmethyl)-
Oprea1_668421
Oprea1_819941
2-(2-benzylbenzimidazol-1-yl)-N,N-diethylethanamine
N-[2-(2-benzyl-1H-benzimidazol-1-yl)ethyl]-N,N-diethylamine
STK053382
AKOS000560079
2-(2-benzyl-1H-benzimidazol-1-yl)-N,N-diethylethanamine